Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial metabolic brain disorder characterized by protein aggregates, synaptic failure, and cognitive impairment. In the AD brain is common to observe the accumulation of senile plaques formed by amyloid-beta (Aβ) peptide and the neurofibrillary tangles composed...

Full description

Saved in:

Bibliographic Details
Main Authors:	María José Pérez, Rodrigo A. Quintanilla
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2015/957248
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
by: Shoko Horita, et al.
Published: (2015-01-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
by: Wei Wei, et al.
Published: (2011-01-01)

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
by: Tianxin Yang, et al.
Published: (2008-01-01)

Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
by: Jerzy Bełtowski, et al.
Published: (2013-01-01)

Neuroplasticity in Alzheimer's disease: a therapeutic alternative at the molecular level
by: Noel Jesús Niebla Gómez, et al.
Published: (2020-08-01)

Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches
by: Almudena Fuster-Matanzo, et al.
Published: (2013-01-01)

A Retrospective Review of Thiazolidinediones with Development of a Troglitazone Conversion Protocol
by: Cameron Lindsey, et al.
Published: (2003-01-01)

Effect of 2,4-Thiazolidinedione on Limousin Cattle Growth and on Muscle and Adipose Tissue Metabolism
by: M. Arévalo-Turrubiarte, et al.
Published: (2012-01-01)

Revisiting Apathy in Alzheimer’s Disease: From Conceptualization to Therapeutic Approaches
by: Antonio L. Teixeira, et al.
Published: (2021-01-01)

Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
by: Alina Simona Șovrea, et al.
Published: (2025-01-01)

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
by: Dan Chen, et al.
Published: (2025-01-01)

Insufficient Sleep and Alzheimer’s Disease: Potential Approach for Therapeutic Treatment Methods
by: Dieu Quynh Trinh, et al.
Published: (2024-12-01)

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)

Biomarker discovery and phytochemical interventions in Alzheimer's disease: A path to therapeutic advances
by: Mithila Debnath, et al.
Published: (2025-02-01)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
by: Linyu Wu, et al.
Published: (2022-01-01)

Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01)

Exposure of Mesenchymal Stem Cells to an Alzheimer’s Disease Environment Enhances Therapeutic Effects
by: Sang Eon Park, et al.
Published: (2021-01-01)

Identification of therapeutic targets for Alzheimer’s Disease Treatment using bioinformatics and machine learning
by: ZhanQiang Xie, et al.
Published: (2025-01-01)

A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
by: Jose Miguel Rubio-Perez, et al.
Published: (2012-01-01)

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
by: Emma Ortiz-Islas, et al.
Published: (2025-01-01)

CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
by: Anchal Sharma, et al.
Published: (2025-02-01)

2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis
by: Fernanda Rosa, et al.
Published: (2017-01-01)

Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01)

The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects
by: Dipanjan Karati, et al.
Published: (2025-06-01)

Controlled Neuronal Death during Aging Might Be an Attractive Therapeutic Target for Preventing Alzheimer's Disease
by: Christoph Schmitz, et al.
Published: (2001-01-01)

Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions
by: Soumilee Chaudhuri, et al.
Published: (2025-01-01)

Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study
by: Nermeen El-Moataz Bellah Ahmed, et al.
Published: (2016-01-01)

The Genetics of Alzheimer’s Disease
by: Robert C. Barber
Published: (2012-01-01)

Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application
by: Yaride Pérez-Pacheco, et al.
Published: (2025-01-01)

Neuropsychiatric symptoms in Alzheimer’s disease
by: J. Vegytė, et al.
Published: (2024-02-01)

Ketogenic diets and Alzheimer’s disease
by: Klaus W. Lange, et al.
Published: (2017-03-01)

Medical foods in Alzheimer’s disease
by: Klaus W. Lange, et al.
Published: (2019-03-01)

False Memory in Alzheimer’s Disease
by: Mohamad El Haj, et al.
Published: (2020-01-01)

Polymers for the treatment of Alzheimer’s disease
by: Yunfeng Zhu, et al.
Published: (2025-01-01)

Alzheimer’s disease pathogenesis and risk factors
by: A. Gerulytė, et al.
Published: (2019-12-01)

Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview
by: María Alejandra Cerquera-Jaramillo, et al.
Published: (2018-01-01)

Systematic review of amyloid-beta clearance proteins from the brain to the periphery: implications for Alzheimer’s disease diagnosis and therapeutic targets
by: Letian Huang, et al.
Published: (2025-12-01)

Adult Hippocampal Neurogenesis in Alzheimer’s Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery
by: Stefano Farioli-Vecchioli, et al.
Published: (2022-01-01)

Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis
by: Shuo Liu, et al.
Published: (2024-01-01)